🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

My 2 cents on the association of PPIs with kidney disease. journals.lww.com/kidney360/cita…

If you manage patients with TB, consider screening for Kidney injury even before starting them on antiTB drugs. Robert Kalyesubula,MD, FISN(USA), PhD-FRCP(London) Dr. Fred C. Semitala @DrBalukuJosep Dr. Edwin Nuwagira Abinet Aklilu 👉 "Incidence of Acute Kidney Injury and Associated Mortality... : Kidney360 journals.lww.com/kidney360/abst…

Check out the papers from a new series in Kidney360: An Update on Onco-nephrology journals.lww.com/kidney360/cita… journals.lww.com/kidney360/abst…

The field of Onco-Nephrology has expanded to become a subspecialty within Nephrology. This series, led by Anushree Shirali & Abinet Aklilu, includes an introduction and ten articles in the following areas: - Novel biomarkers and imaging for AKI diagnosis in patients with cancer -

Diversity, collegiality and excellence to be expected soon American Society of Nephrology American Society of Onconephrology by Anushree Shirali and Abinet Aklilu

PPI use is a/w a slight ⬆️ CKD risk, but the nature of this risk remains uncertain & unexplained. We clearly need more definitive data, but are unlikely to get it. Read Mark Perazella’s perspective in ASN Kidney360!👇 journals.lww.com/kidney360/full…

Thrilled and very proud of Abinet Aklilu who will be presenting the results of the Kidney Action Team Trial at #kidneywk in San Diego this month. Did personalized, real-time recommendations for initial diagnosis and management of AKI (N=4,003) move the needle on AKI outcomes?

Thread of simultaneous pubs from #KidneyWk jamanetwork.com/journals/jamap… in JAMA Pediatrics from Michelle Starr MD MPH et al Long term follow up of the RIVUR trial, now demonstrating that Abx therapy *was* associated with slower GFR loss in VUR + UTI subgroup 1/

Here we go, #kidneywk! Abinet Aklilu presenting the results of the Kidney Action Team Randomized Trial at the High-Impact Clinical Trials session in Hall D at 11am! I'll add to this thread as the presentation happens. Big question: Would rapid, personalized recommendations within

The KAT-AKI trial from F. Perry Wilson, MD MSCE and team is live at JAMA jamanetwork.com/journals/jama/… #KidneyWk

📸 Megan Baker giving her first oral presentation at American Society of Nephrology #KidneyWk this afternoon, on her work characterizing immune-tubulointerstitial interactions in AIN and ATI! Lloyd Cantley Dennis Moledina, MD PhD

Congratulations to current Yale faculty Ladan Golestaneh and former Yale faculty Neera Dahl on receiving the Distinguished Clinical Service Award at American Society of Nephrology #KidneyWk!!! So well deserved for both!

K360 series on Update in Onco-Nephrology continues in this issue, with Miguel Bigotte Vieira and Naoka Murakami discussing cancer screening and treatment considerations in KTRs. Abinet Aklilu American Society of Onconephrology

🔥 ✨ Enjoy our study on Incidence of Acute Kidney Injury and Associated Mortality among Individuals with Drug-Susceptible Tuberculosis in Uganda. 👉 AKI/TB kills! Dr Kansiime Grace Abinet Aklilu F. Perry Wilson, MD MSCE Ursula Brewster Dr. Baluku Joseph Dr. Oriba Dan Langoya journals.lww.com/kidney360/full…

New in JASN_News : external validation of a diagnostic model for predicting biopsy-proven AIN increased AUC of clinicians' prebiopsy suspicion for AIN by 0.10 to 0.77! Awesome tool! Dennis Moledina, MD PhD Abinet Aklilu F. Perry Wilson, MD MSCE Chirag Parikh Yale Internal Medicine journals.lww.com/jasn/abstract/…

Although tuberculosis (TB) is associated with significant mortality and morbidity, its impact on kidney function is not well understood and is often attributed to anti-TB drugs. This study found that the overall incidence of AKI in the immediate post-TB diagnosis period is high